These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 1356787)
1. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Berger UV; Gu XF; Azmitia EC Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787 [TBL] [Abstract][Full Text] [Related]
2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
3. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Series HG; Cowen PJ; Sharp T Psychopharmacology (Berl); 1994 Dec; 116(4):508-14. PubMed ID: 7535469 [TBL] [Abstract][Full Text] [Related]
4. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Crespi D; Mennini T; Gobbi M Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711 [TBL] [Abstract][Full Text] [Related]
5. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release. Wichems CH; Hollingsworth CK; Bennett BA Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641 [TBL] [Abstract][Full Text] [Related]
6. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats. Schmidt CJ; Black CK; Taylor VL Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766 [TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Hekmatpanah CR; Peroutka SJ Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219 [TBL] [Abstract][Full Text] [Related]
8. In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Kramer K; Azmitia EC; Whitaker-Azmitia PM Brain Res Dev Brain Res; 1994 Mar; 78(1):142-6. PubMed ID: 7911745 [TBL] [Abstract][Full Text] [Related]
9. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054 [TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. McKenna DJ; Guan XM; Shulgin AT Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838 [TBL] [Abstract][Full Text] [Related]
11. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435 [TBL] [Abstract][Full Text] [Related]
12. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons. Gu XF; Azmitia EC Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196 [TBL] [Abstract][Full Text] [Related]
13. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action. McElroy JF; Miller JM; Meyer JS J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT). Kramer HK; Poblete JC; Azmitia EC Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590 [TBL] [Abstract][Full Text] [Related]
16. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637 [TBL] [Abstract][Full Text] [Related]
17. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Johnson MP; Conarty PF; Nichols DE Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125 [TBL] [Abstract][Full Text] [Related]
18. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD; Nichols DE; Yim GK Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Schmidt CJ; Levin JA; Lovenberg W Biochem Pharmacol; 1987 Mar; 36(5):747-55. PubMed ID: 2881549 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. Gazzara RA; Takeda H; Cho AK; Howard SG Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]